Twin Lakes Capital Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Twin Lakes Capital Management's NVS Position: Q2 2026 in Review
Twin Lakes Capital Management held its Novartis (NVS) position steady in Q2 2026 at 3,830 shares worth $600K. The position accounts for 0.23% of the portfolio, ranked #54.
Twin Lakes Capital Management first reported a position in NVS in Q4 2020 and has held it in 23 quarters since. 1,621 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Twin Lakes Capital Management held 3,830 shares of Novartis worth $600K as of Q2 2026.
- Twin Lakes Capital Management left its Novartis share count unchanged in Q2 2026.
- Novartis made up 0.23% of Twin Lakes Capital Management's portfolio in Q2 2026, its #54 holding.
- Twin Lakes Capital Management first reported a position in Novartis in Q4 2020 and has held it in 23 quarters since.
- 1,621 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Twin Lakes Capital Management's 13F filing for Q2 2026, filed 18 Aug 2026.